Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $821.28 | 13 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $241.08 | 3 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $183.01 | 4 | $0 (2024) |
| Amgen Inc. | $150.00 | 1 | $0 (2024) |
| ViiV Healthcare Company | $117.52 | 1 | $0 (2024) |
| Lilly USA, LLC | $83.52 | 1 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $30.78 | 2 | $0 (2022) |
| Astellas Pharma US Inc | $15.37 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $491.86 | 4 | Amgen Inc. ($150.00) |
| 2022 | $96.90 | 2 | Lilly USA, LLC ($83.52) |
| 2021 | $232.52 | 7 | Novo Nordisk Inc ($139.10) |
All Payment Transactions
13 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/06/2024 | ViiV Healthcare Company | APRETUDE (Biological) | Food and Beverage | In-kind items and services | $117.52 | General |
| Category: HIV | ||||||
| 08/29/2024 | Amgen Inc. | EVENITY (Biological) | Food and Beverage | In-kind items and services | $150.00 | General |
| Category: Bone Health | ||||||
| 03/07/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $122.36 | General |
| Category: DIABETES | ||||||
| 02/01/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $101.98 | General |
| Category: Obesity | ||||||
| 11/10/2022 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $13.38 | General |
| 10/06/2022 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | Cash or cash equivalent | $83.52 | General |
| Category: Diabetes | ||||||
| 09/23/2021 | Novo Nordisk Inc | RYBELSUS (Drug), Ozempic | Food and Beverage | In-kind items and services | $20.68 | General |
| Category: Diabetes | ||||||
| 07/22/2021 | Novo Nordisk Inc | RYBELSUS (Drug) | Food and Beverage | In-kind items and services | $118.42 | General |
| Category: Diabetes | ||||||
| 03/23/2021 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $15.37 | General |
| Category: UROLOGY | ||||||
| 03/19/2021 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.40 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/16/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.26 | General |
| Category: DIABETES | ||||||
| 02/03/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.86 | General |
| Category: DIABETES | ||||||
| 01/08/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $21.53 | General |
| Category: DIABETES | ||||||
About Linda Herrera, FNP
Linda Herrera, FNP is a Nurse Practitioner healthcare provider based in Weslaco, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/29/2017. The National Provider Identifier (NPI) number assigned to this provider is 1417474503.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Linda Herrera, FNP has received a total of $821.28 in payments from pharmaceutical and medical device companies, with $491.86 received in 2024. These payments were reported across 13 transactions from 7 companies. The most common payment nature is "Food and Beverage" ($821.28).
Practice Information
- Specialty Nurse Practitioner
- Location Weslaco, TX
- Active Since 08/29/2017
- Last Updated 06/04/2020
- Taxonomy Code 363L00000X
- Entity Type Individual
- NPI Number 1417474503
Products in Payments
- JARDIANCE (Drug) $183.01
- EVENITY (Biological) $150.00
- RYBELSUS (Drug) $139.10
- APRETUDE (Biological) $117.52
- Wegovy (Drug) $101.98
- MOUNJARO (Drug) $83.52
- FARXIGA (Drug) $17.40
- MYRBETRIQ (Drug) $15.37
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nurse Practitioner Doctors in Weslaco
David Womble, Cnp, CNP
Nurse Practitioner — Payments: $1,270
Maria Garcia, Np, NP
Nurse Practitioner — Payments: $146.41
Margareth Libiran, Nurse Practioner, NURSE PRACTIONER
Nurse Practitioner — Payments: $112.10
Francisco Sanchez, Fnp, FNP
Nurse Practitioner — Payments: $40.45
Ms. Tommie Lightsey, Aprn, APRN
Nurse Practitioner
Mr. Stephen Guillot, Np, NP
Nurse Practitioner